Management Services Organizations (MSOs) have fundamentally transformed the dermatology landscape. Over the past decade, PE-backed MSO platforms have acquired hundreds of independent practices, creating regional and national derm networks that now represent a significant share of the specialty.
If you're considering selling your dermatology practice to an MSO, understanding exactly how these deals work—and what you're giving up in exchange for a significant payday—is critical for making the right decision for your career and finances.
The MSO Reality Check
Dermatology MSOs typically pay 6-12x EBITDA for practices, with the largest, most desirable practices commanding the top of that range. But the headline number is only part of the equation—rollover equity, employment terms, and earnouts dramatically affect your actual proceeds.
What Is an MSO in Dermatology?
An MSO (Management Services Organization) is a legal structure that allows private equity to effectively "own" physician practices without violating state corporate practice of medicine laws. Here's how it works:
The Legal Structure
- MSO (Management Company) Owns non-clinical assets: equipment, leases, contracts, goodwill, intellectual property, billing systems
- Professional Corporation (PC) Employs physicians, delivers medical care, maintains professional licenses
- Management Services Agreement The MSO provides administrative services to the PC in exchange for a management fee (typically 15-25% of collections)
When you "sell to an MSO," you're actually selling the non-clinical assets to the MSO and becoming an employee of a professional corporation that contracts with the MSO. This structure complies with corporate practice of medicine regulations while giving PE economic control.
Anatomy of an MSO Deal
Understanding the components of an MSO transaction helps you evaluate offers intelligently:
| Component | Typical Range | What It Means |
|---|---|---|
| Purchase Multiple | 6-12x EBITDA | Total enterprise value based on normalized earnings |
| Cash at Close | 60-80% of total | Money wired to you on closing day |
| Rollover Equity | 20-40% of total | Reinvested into the MSO platform for future appreciation |
| Earnout | 0-20% of total | Contingent payments based on post-sale performance |
| Employment Term | 3-5 years | Minimum commitment to work for the platform |
| Non-Compete | 2-5 years, 10-25 miles | Geographic and temporal restrictions post-departure |
The "Second Bite" Explained
One of the most compelling aspects of MSO deals is the potential for a "second bite of the apple." Here's how it works:
- First Transaction: You sell your practice for 8x EBITDA, receiving 70% cash and rolling 30% into platform equity
- Platform Growth: The MSO acquires additional practices, centralizes operations, and grows EBITDA
- Second Transaction: 4-6 years later, the PE sponsor sells the entire platform to a larger buyer at 10-12x EBITDA
- Your Payout: Your rolled equity participates in the platform sale, potentially doubling or tripling in value
Second Bite Math
If you roll $1M into a platform at 8x entry and the platform sells at 12x (1.5x step-up), your $1M becomes $1.5M. But if the platform 3x'd EBITDA through growth, your $1M could become $4.5M. The second bite can exceed your original cash proceeds—but it's not guaranteed.
What MSOs Want in Dermatology Practices
Not all practices are equally attractive to MSO buyers. Here's what commands premium valuations:
Premium Indicators
- Multiple providers 3+ dermatologists significantly reduces key-person risk
- Strong cosmetic mix 25-40% revenue from cash-pay aesthetic services
- Mohs surgery High-margin, in-demand service with excellent reimbursement
- In-house pathology Capturing derm path economics adds margin
- PA/NP leverage Mid-levels extending physician reach
- Growth trajectory Increasing revenue and EBITDA trends
- Attractive geography Suburban, affluent markets with room to grow
Value Detractors
- Solo practice All revenue tied to one physician's continued effort
- 100% medical derm No aesthetic upside for buyer to capture
- Declining production Sellers approaching burnout get lower multiples
- Poor payer mix Heavy Medicaid or low commercial penetration
- Lease expiring Location uncertainty creates risk
Critical Terms to Negotiate
The purchase price is just one piece of the puzzle. These terms often matter more for your actual outcome:
Employment Agreement Terms
- Base salary Should be at or above fair market value for your production
- Productivity bonus Typically RVU-based or collections-based; understand the thresholds
- Benefits package Health insurance, malpractice, retirement contributions
- Call requirements How will weekend and holiday coverage change?
- PTO and CME Vacation time and continuing education support
Equity Terms
- Valuation methodology How is the platform valued for your rollover?
- Governance rights Do you have any say in platform decisions?
- Drag-along provisions Can you be forced to sell in the next transaction?
- Put/call rights What happens if you leave or want to cash out early?
- Distribution policy Are there any dividends, or is all value locked until exit?
Earnout Protections
- Measurement period How long and what metrics?
- Calculation methodology Who controls the numbers?
- Allocation of corporate overhead How are shared costs charged to your practice?
- Dispute resolution What happens if you disagree with the calculation?
| What Changes Post-Sale | Typical Impact |
|---|---|
| Clinical Autonomy | Usually preserved, but corporate policies apply |
| Administrative Burden | Reduced—MSO handles billing, HR, IT, compliance |
| Hiring/Firing Decisions | Shared with or delegated to MSO management |
| Purchasing | Centralized by MSO for economies of scale |
| Marketing | Coordinated by platform; some local discretion |
| Growth Expectations | Platforms want to grow; expect pressure to add volume or providers |
Red Flags in MSO Deals
- Unusually high rollover 50%+ rollover shifts risk to you and reduces cash
- Aggressive earnout structure More than 20% contingent is concerning
- Below-market employment terms The purchase price doesn't matter if your salary is cut 30%
- Vague governance rights No transparency on platform decisions affecting your equity
- Restrictive put/call terms Can you ever exit your investment without platform sale?
- Non-compete overreach 5+ year, 50+ mile restrictions are excessive
What's Your Dermatology Practice Worth?
Our valuation calculator uses specialty-specific multiples to give you an instant estimate. Takes 60 seconds—no contact info required.
Request Confidential ValuationIs Selling to an MSO Right for You?
The MSO path is excellent for some dermatologists and wrong for others. Consider these factors:
MSO Sale May Be Right If You:
- Want to monetize practice value while continuing to practice
- Are ready to reduce administrative burden and focus on clinical care
- Have 5-10+ working years remaining and can benefit from second bite
- Are comfortable transitioning from owner to employed physician
- Want resources to grow (marketing, capital, operational support)
MSO Sale May Not Be Right If You:
- Value complete autonomy over all practice decisions
- Plan to retire within 2-3 years (employment commitment won't fit)
- Are philosophically opposed to corporate influence on medicine
- Have a solo practice and aren't willing to commit to 3-5 year employment
Next Steps
- Get a realistic valuation Understand what MSOs are actually paying for practices like yours
- Talk to dermatologists who've done it Honest perspectives from those who've sold are invaluable
- Engage experienced advisors Healthcare M&A attorney and transaction advisor who know derm
- Run a competitive process Multiple interested parties create leverage for better terms
Start With Your Valuation
The first step in evaluating MSO interest is understanding your practice's market value. Get a free, confidential estimate.
Calculate My Practice ValueRelated Resources
- Sell My Dermatology Practice: Complete guide to derm practice exits
- What Is an MSO in Healthcare?: MSO structures explained
- Selling to Private Equity: How PE deals work
- Dermatology Practices for Sale: Market overview